摘要
目的:研究肾癌冻融抗原负载树突状细胞(DCs)诱导的特异性细胞毒性T淋巴细胞(CTL)对肾癌786-0细胞株的体外杀伤效应;方法:利用人外周血体外经重组人粒细胞-巨噬细胞集落刺激因子(rhGM-CSF)、人白介素-4(rhIL-4)和肿瘤坏死因子(TNF-α)诱导产生的DCs负载肾癌冻融裂解物后诱导产生特异性CTL,观察杀伤后肿瘤细胞的形态变化,MTT法测定细胞毒性试验,ELISA测定细胞因子的分泌。结果:(1)负载肾癌抗原的DCs能促进T细胞的增殖;(2)诱导产生的特异性CTL对肾癌细胞具有高杀伤率,显著高于非特异性T细胞(P<0.05);(3)肾癌冻融抗原能够上调DCs人白介素-12(rhIL-12)的分泌,提高抗肿瘤的作用。(4)杀伤后的肾癌细胞发生明显凋亡。结论:由肾癌冻融抗原致敏的DCs所诱导产生的抗原特异性CTL对肾癌786-0细胞株有明显的杀伤效应,提示DCs瘤苗具有为肾癌患者进行特异性过继免疫治疗的临床应用前景。
Objective: To study the immune responses of cytotoxic T-lymphocytes against Renal carcinoma cell 786-0 (RCC) after activiated by dendritic cells(DCs) loaded with RCC freeze thawing antigen. Methods:DCs were obtained by cultured plastic-adherent monocytes isolated from health human peripheral blood with granulocyte-monocyte colony-stimulating factor(GM-CSF) and interleukin-4(IL-4) and Tumor necrosis factor ( TNF ) for 9 days.Host lymphocytes were stimulated with freeze thawing antigen of RCC 786-0 under the culture medium containing interleukin-2(IL-2) for 5 day. Killing activity and cytokine release were measured by MTT assay and ELISA. Results: The immune response of CTL activiated by DCs loaded with tumor soluble antigen was demonstrated by the following facts: ( 1 ) DCs loaded with tumor antigen could induce the growth of CTL. ( 2 ) The cyotoxicity of obtained specific CTL against RCC-7860 was highly enhanced with a significant difference from that of non-specific CTL. ( 3 )The interleukin-12 release/secretion was increased by tumor antigen,which suggest an improved anti-tumor effect. ( 4 ) Apoptosis was observed in the RCCs after treated with CTL obtained. Conclution: These findings indicate that specific CTL induced by DCs sensibilized by RCC freeze thawing antigen exerts a remarkable killing activity on RCC 786-0. It is suggestd that DCs antitumor vaccines poses a clinically useful prospect with RCC.
出处
《重庆医科大学学报》
CAS
CSCD
2006年第4期513-517,551,共6页
Journal of Chongqing Medical University
基金
重庆市卫生局项目(编号05-2-024)